Description     Claims     Drawing  

US4940583A   [0010]  [0082] 
US4923685A   [0010]  [0082] 
US4579677A   [0010] 
US4311617A   [0010]  [0082] 
US5260313A   [0010]  [0035]  [0082] 
US4599677A   [0082] 
US20030224072A   [0082] 

Sodium Channel Blockers in Neuropathic Pain   [0081] 
Antidepressants in the Treatment of Neuropathic Pain   [0081] 
Anticonvulsants in neuropathic pain: rationale and clinical evidence   [0081] 
A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes   [0081] 
Efficacy and Safety of Opioid Agonists in the Treatment of Neuropathic Pain of Nonmalignant Origin   [0081] 
Baclofen as an adjuvant analgesic   [0081] 
Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of postherpetic neuralgia   [0081] 
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action   [0081] 
Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration   [0081] 
Temporary relief of postherpetic neuralgia pain with topical geranium oil   [0081] 
Antiinflammatory and antinociceptive activities of zingiber officinale roscoe essential oil in experimental animal models   [0081] 
Menthol: a natural analgesic compound Neuroscience Letters   [0081] 
NEUROLOGY   [0081] 
MD Randomized controlled trial of cannabis-based medicine in central pain in multiple sclerosis   [0081] 
K+ channels as therapeutic drug targets   [0081] 
New Jersey Dept of Health Hazardous Substance Fact Sheet   [0081] 
GABA Receptor Channel Pharmacology   [0081] 
+) and (-)- borneol: efficacious positive modulators of GABA action   [0081]